Symbiotic-Lung-01: A phase 3 trial of PF-08634404, a PD-1/VEGF bispecific antibody, vs pembrolizumab plus platinum-based chemotherapy in first-line for locally advanced or metastatic non-small cell lung cancer (NSCLC) (ESMO Asia 2026) - Oct 1, 2026 - Abstract #1016TiP; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Bispecific • Clinical • Metastases • P3 data • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • PD-1
|
|
David Planchard; Martin Reck; Rachel Roberts-Thomson; Vishal Navani; Caicun Zhou; Akito Hata; Yasushi Goto; Noelia Vilariño; Enriqueta Felip; Luis Paz-Ares; James Chih-Hsin Yang; Jhanelle E. Gray; Smitha Menon; Matthew M. Mirsky; June Kim; Matteo Setti; Melissa L. Johnson
|